Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Shree Ganesh Remedies Ltd
Score 48/100• Decent
Shree Ganesh Remedies Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
Company’s Health97/100
Valuation 40/100 · PB 4.4338
Technical Avoid
1M -9.595% 6M -27.671% 1Y -37.131%
Confidence100%
Low leverage (D/E)No promoter pledge
#181
View details ➜
S
Saroja Pharma Industries India Ltd
Score 48/100• Risky
Saroja Pharma Industries presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health69/100
Valuation 80/100 · PB 1.2308
Technical Avoid
1M 2.128% 6M 5.495% 1Y -20.988%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#182
View details ➜
S
Sanofi Consumer Healthcare India Ltd
Score 48/100• Decent
Sanofi Consumer Healthcare India Ltd shows potential but faces challenges in profitability and execution risks.
Company’s Health100/100
Valuation 20/100 · PB 39.4043
Technical Avoid
1M -10.429% 6M -5.737% 1Y -3.334%
Confidence100%
Low leverage (D/E)No promoter pledge
#183
View details ➜
M
Marksans Pharma Ltd
Score 48/100• Decent
Marksans Pharma Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health90/100
Valuation 40/100 · PB 3.2896
Technical Avoid
1M 4.537% 6M -14.36% 1Y -38.649%
Confidence100%
Low leverage (D/E)No promoter pledge
#184
View details ➜
L
Link Pharmachem Ltd
Score 48/100• Risky
Link Pharmachem Ltd presents a risky investment opportunity due to inconsistent growth, profitability concerns, and high valuation metrics compared to peers.
Company’s Health46/100
Valuation 80/100 · PB 1.242
Technical Avoid
1M 9.736% 6M -0.701% 1Y -20.194%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#185
View details ➜
L
Lincoln Pharmaceuticals Ltd
Score 48/100• Decent
Lincoln Pharmaceuticals shows potential but faces challenges in profitability and market sentiment.
Company’s Health83/100
Valuation 80/100 · PB 1.5726
Technical Avoid
1M -6.079% 6M -6.829% 1Y -21.461%
Confidence100%
Low leverage (D/E)No promoter pledge
#186
View details ➜
I
Influx Healthtech Ltd
Score 48/100• Risky
Influx Healthtech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health100/100
Valuation 20/100 · PB 11.271
Technical Avoid
1M 0.414% 6M 39.461% 1Y 39.461%
Confidence100%
Low leverage (D/E)No promoter pledge
#187
View details ➜
R
Rajnish Wellness Ltd
Score 48/100• Risky
Rajnish Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health53/100
Valuation 80/100 · PB 1.0617
Technical Avoid
1M -20% 6M -10.167% 1Y -71.349%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#188
View details ➜
R
Raaj Medisafe India Ltd
Score 48/100• Risky
The stock presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
Company’s Health84/100
Valuation 40/100 · PB 3.5951
Technical Avoid
1M 3.74% 6M 6.868% 1Y -30.204%
Confidence100%
No promoter pledgeDecent revenue growth
#189
View details ➜
Q
Qualitek Labs Ltd
Score 48/100• Risky
Qualitek Labs Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health92/100
Valuation 20/100 · PB 5.362
Technical Watch
1M 0% 6M 45.833% 1Y 30.681%
Confidence100%
No promoter pledge
#190
View details ➜
Q
QMS Medical Allied Services Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health91/100
Valuation 80/100 · PB 1.8706
Technical Avoid
1M 11.701% 6M 0.183% 1Y -12.455%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#191
View details ➜
M
Mohini Health & Hygiene Ltd
Score 48/100• Risky
Mohini Health & Hygiene Ltd presents several risks, particularly in profitability and market sentiment, making it a risky investment at this time.
Company’s Health63/100
Valuation 100/100 · PB 0.8792
Technical Avoid
1M -5.872% 6M -8.147% 1Y -11.931%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#192
View details ➜
M
Maitreya Medicare Ltd
Score 48/100• Risky
Maitreya Medicare Ltd shows potential in a growing sector, but significant risks and inconsistencies in performance make it a risky investment.
Company’s Health74/100
Valuation 20/100 · PB 5.1361
Technical Avoid
1M 1.126% 6M -20.282% 1Y -31.921%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#193
View details ➜
K
Kopran Ltd
Score 48/100• Risky
Kopran Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
Company’s Health73/100
Valuation 80/100 · PB 1.5664
Technical Avoid
1M -6.455% 6M -15.596% 1Y -43.583%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#194
View details ➜
K
KOBO Biotech Ltd
Score 48/100• Risky
KOBO Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health41/100
Valuation 100/100 · PB -0.0456
Technical Avoid
1M 3.913% 6M -15.517% 1Y -18.874%
Confidence100%
No promoter pledgeReasonable PB valuation
Thin margins
#195
View details ➜
Showing 181 to 195 of 260 (18 Pages)